| SC 13D | 2015-08-31 | HealthCare Ventures VIII, L.P. | CATALYST BIOSCIENCES, INC. | 1,068,717 | 9.3% | EDGAR |
| SC 13D | 2015-08-31 | Morgenthaler Partners VIII LP | CATALYST BIOSCIENCES, INC. | 905,558 | 7.9% | EDGAR |
| SC 13D | 2015-08-31 | Essex Woodlands Health Ventures VIII, L.L.C. | CATALYST BIOSCIENCES, INC. | 1,226,519 | 10.7% | EDGAR |
| SC 13D | 2015-08-28 | Rosetta Capital V LP | CATALYST BIOSCIENCES, INC. | 772,784 | 6.8% | EDGAR |
| SC 13G | 2015-08-28 | JOHNSON & JOHNSON | CATALYST BIOSCIENCES, INC. | 1,029,144 | 9.0% | EDGAR |
| SC 13D/A | 2015-08-21 | BIOTECHNOLOGY VALUE FUND L P | CATALYST BIOSCIENCES, INC. | 579,023 | 5.0% | EDGAR |
| SC 13G | 2015-08-21 | BIOTECHNOLOGY VALUE FUND L P | CATALYST BIOSCIENCES, INC. | 579,023 | 5.0% | EDGAR |
| SC 13D/A | 2015-08-07 | BIOTECHNOLOGY VALUE FUND L P | TARGACEPT INC | 2,977,919 | 8.7% | EDGAR |
| SC 13D/A | 2015-05-18 | NEW ENTERPRISE ASSOCIATES 10 L P | TARGACEPT INC | 4,563,512 | 13.5% | EDGAR |
| SC 13D/A | 2015-05-15 | BIOTECHNOLOGY VALUE FUND L P | TARGACEPT INC | 2,977,919 | 8.8% | EDGAR |
| SC 13D/A | 2015-03-18 | BIOTECHNOLOGY VALUE FUND L P | TARGACEPT INC | 2,977,919 | 8.8% | EDGAR |
| SC 13D/A | 2015-03-17 | NEW ENTERPRISE ASSOCIATES 10 L P | TARGACEPT INC | 4,563,512 | 13.3% | EDGAR |
| SC 13G/A | 2015-02-17 | RTW INVESTMENTS, LLC | TARGACEPT INC | 2,665,643 | 7.8% | EDGAR |
| SC 13D | 2015-02-10 | BIOTECHNOLOGY VALUE FUND L P | TARGACEPT INC | 2,977,919 | 8.7% | EDGAR |
| SC 13D | 2014-09-05 | BIOTECHNOLOGY VALUE FUND L P | TARGACEPT INC | 2,977,919 | 8.8% | EDGAR |
| SC 13G/A | 2014-07-10 | BlackRock Inc. | TARGACEPT INC | 1,125,262 | 3.3% | EDGAR |
| SC 13G/A | 2014-07-10 | BlackRock Inc. | TARGACEPT INC | 1,125,262 | 3.3% | EDGAR |
| SC 13G | 2014-06-11 | RTW INVESTMENTS, LLC | TARGACEPT INC | 1,930,407 | 5.7% | EDGAR |
| SC 13G/A | 2014-01-30 | BlackRock Inc. | TARGACEPT INC | 2,433,983 | 7.2% | EDGAR |
| SC 13G/A | 2013-09-10 | FMR LLC | TARGACEPT INC | 471,249 | 1.4% | EDGAR |